Inventory, Net of China SXT Pharmaceuticals, Inc. from 31 Mar 2018 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary: China SXT Pharmaceuticals, Inc. quarterly Inventory, Net in USD history and change rate from 31 Mar 2018 to 31 Mar 2025.
China SXT Pharmaceuticals, Inc. Inventory, Net for the quarter ending 31 Mar 2025 was $828,053, a 4.2% increase year-over-year.
Source SEC data: View on sec.gov

Inventory, Net, Quarterly (USD)

Inventory, Net, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Inventory, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$828,053	+$33,198	+4.2%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q3 2024	$867,233	+$374,019	+76%	30 Sep 2024	6-K	28 Mar 2025	2025	Q2
Q1 2024	$794,855	+$263,601	+50%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q3 2023	$493,214	-$134,972	-21%	30 Sep 2023	6-K	05 Apr 2024	2024	Q2
Q1 2023	$531,254	-$486,273	-48%	31 Mar 2023	20-F	13 Aug 2024	2024	FY
Q3 2022	$628,186	-$209,261	-25%	30 Sep 2022	6-K	24 Feb 2023	2023	Q2
Q1 2022	$1,017,527	+$157,831	+18%	31 Mar 2022	20-F	31 Jul 2023	2023	FY
Q3 2021	$837,447	-$29,834	-3.4%	30 Sep 2021	6-K	14 Jan 2022	2022	Q2
Q1 2021	$859,696	-$33,071	-3.7%	31 Mar 2021	20-F/A	19 May 2023	2022	FY
Q3 2020	$867,281	+$21,000	+2.5%	30 Sep 2020	6-K	28 Jan 2021	2021	Q2
Q1 2020	$892,767	-$115,151	-11%	31 Mar 2020	20-F	13 Aug 2021	2021	FY
Q3 2019	$846,281			30 Sep 2019	6-K/A	22 May 2020	2020	Q2
Q1 2019	$1,007,918	-$258,962	-20%	31 Mar 2019	20-F	31 Jul 2020	2020	FY
Q1 2018	$1,266,880			31 Mar 2018	20-F	15 Aug 2019	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.